Get started
DDD

DIAMYD MEDICAL AB

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

DMN chart


Full chart

Key stats


Market capitalization
‪114.55 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.14 EUR
Net income (FY)
‪−13.32 M‬ EUR
Revenue (FY)
‪11.40 K‬ EUR
Shares float
‪86.36 M‬
Beta (1Y)
0.25

About DIAMYD MEDICAL AB SER. B


Sector
Health Technology
CEO
Ulf Hannelius
Headquarters
Stockholm
Website
diamyd.com
Founded
1984
ISIN
SE0005162880
FIGI
BBG00LV487B4
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. It also develops and invests in stem cell and medical technology. The company was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

DMN news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DMN is 1.05 EUR — it has decreased by −4.01% in the past 24 hours. Watch DIAMYD MEDICAL AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange DIAMYD MEDICAL AB stocks are traded under the ticker DMN.
DMN stock has fallen by −2.23% compared to the previous week, the month change is a −7.71% fall, over the last year DIAMYD MEDICAL AB has showed a 69.63% increase.
DMN reached its all-time high on Mar 3, 2021 with the price of 3.93 EUR, and its all-time low was 0.56 EUR and was reached on Oct 25, 2023. View more price dynamics on DMN chart.
See other stocks reaching their highest and lowest prices.
DMN stock is 9.15% volatile and has beta coefficient of 0.25. Track DIAMYD MEDICAL AB stock price on the chart and check out the list of the most volatile stocks — is DIAMYD MEDICAL AB there?
Today DIAMYD MEDICAL AB has the market capitalization of ‪113.30 M‬, it has increased by 1.93% over the last week.
Yes, you can track DIAMYD MEDICAL AB financials in yearly and quarterly reports right on TradingView.
DMN net income for the last quarter is ‪−4.36 M‬ EUR, while the quarter before that showed ‪−3.50 M‬ EUR of net income which accounts for −24.82% change. Track more DIAMYD MEDICAL AB financial stats to get the full picture.
No, DMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIAMYD MEDICAL AB EBITDA is ‪−12.71 M‬ EUR, and current EBITDA margin is ‪−111.42 K‬%. See more stats in DIAMYD MEDICAL AB financial statements.
Like other stocks, DMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIAMYD MEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIAMYD MEDICAL AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIAMYD MEDICAL AB stock shows the sell signal. See more of DIAMYD MEDICAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.